1 Report Overview
1.1 Study Scope
1.2 Major Manufacturers Covered in This Report
1.3 Market Segment by Type
1.3.1 Global Retinal Drugs and Biologics Market Size Growth Rate by Type (2020-2025)
1.3.2 Age Related Macular Degeneration
1.3.3 Diabetic Retinopathy
1.3.4 Ocular Inflammatory Disease (Uveitis)
1.3.5 Macular Hole
1.4 Market Segment by Application
1.4.1 Global Retinal Drugs and Biologics Market Share by Application (2020-2025)
1.4.2 Hospitals
1.4.3 Clinics
1.4.4 Others
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Retinal Drugs and Biologics Market Size
2.1.1 Global Retinal Drugs and Biologics Revenue 2015-2025
2.1.2 Global Retinal Drugs and Biologics Sales 2015-2025
2.2 Retinal Drugs and Biologics Growth Rate by Regions
2.2.1 Global Retinal Drugs and Biologics Sales by Regions 2015-2019
2.2.2 Global Retinal Drugs and Biologics Revenue by Regions 2015-2019
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
3 Market Share by Manufacturers
3.1 Retinal Drugs and Biologics Sales by Manufacturers
3.1.1 Retinal Drugs and Biologics Sales by Manufacturers 2015-2019
3.1.2 Retinal Drugs and Biologics Sales Market Share by Manufacturers 2015-2019
3.2 Revenue by Manufacturers
3.2.1 Retinal Drugs and Biologics Revenue by Manufacturers (2015-2019)
3.2.2 Retinal Drugs and Biologics Revenue Share by Manufacturers (2015-2019)
3.2.3 Global Retinal Drugs and Biologics Market Concentration Ratio (CR5 and HHI)
3.3 Retinal Drugs and Biologics Price by Manufacturers
3.4 Key Manufacturers Retinal Drugs and Biologics Plants/Factories Distribution and Area Served
3.5 Date of Key Manufacturers Enter into Retinal Drugs and Biologics Market
3.6 Key Manufacturers Retinal Drugs and Biologics Product Offered
3.7 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Sales and Revenue for Each Type
4.1.1 Age Related Macular Degeneration Sales and Revenue (2015-2019)
4.1.2 Diabetic Retinopathy Sales and Revenue (2015-2019)
4.1.3 Ocular Inflammatory Disease (Uveitis) Sales and Revenue (2015-2019)
4.1.4 Macular Hole Sales and Revenue (2015-2019)
4.2 Global Retinal Drugs and Biologics Sales Market Share by Type
4.3 Global Retinal Drugs and Biologics Revenue Market Share by Type
4.4 Retinal Drugs and Biologics Price by Type
5 Market Size by Application
5.1 Overview
5.2 Global Retinal Drugs and Biologics Sales by Application
6 United States
6.1 United States Retinal Drugs and Biologics Breakdown Data by Company
6.2 United States Retinal Drugs and Biologics Breakdown Data by Type
6.3 United States Retinal Drugs and Biologics Breakdown Data by Application
7 European Union
7.1 European Union Retinal Drugs and Biologics Breakdown Data by Company
7.2 European Union Retinal Drugs and Biologics Breakdown Data by Type
7.3 European Union Retinal Drugs and Biologics Breakdown Data by Application
8 China
8.1 China Retinal Drugs and Biologics Breakdown Data by Company
8.2 China Retinal Drugs and Biologics Breakdown Data by Type
8.3 China Retinal Drugs and Biologics Breakdown Data by Application
9 Rest of World
9.1 Rest of World Retinal Drugs and Biologics Breakdown Data by Company
9.2 Rest of World Retinal Drugs and Biologics Breakdown Data by Type
9.3 Rest of World Retinal Drugs and Biologics Breakdown Data by Application
9.4 Rest of World Retinal Drugs and Biologics Breakdown Data by Countries
9.4.1 Rest of World Retinal Drugs and Biologics Sales by Countries
9.4.2 Rest of World Retinal Drugs and Biologics Revenue by Countries
9.4.3 Japan
9.4.4 Korea
9.4.5 India
9.4.6 Southeast Asia
10 Company Profiles
10.1 ALLERGAN
10.1.1 ALLERGAN Company Details
10.1.2 Company Description and Business Overview
10.1.3 Sales, Revenue and Market Share of Retinal Drugs and Biologics
10.1.4 Retinal Drugs and Biologics Product Introduction
10.1.5 ALLERGAN Recent Development
10.2 AbbVie
10.2.1 AbbVie Company Details
10.2.2 Company Description and Business Overview
10.2.3 Sales, Revenue and Market Share of Retinal Drugs and Biologics
10.2.4 Retinal Drugs and Biologics Product Introduction
10.2.5 AbbVie Recent Development
10.3 Alimera Sciences
10.3.1 Alimera Sciences Company Details
10.3.2 Company Description and Business Overview
10.3.3 Sales, Revenue and Market Share of Retinal Drugs and Biologics
10.3.4 Retinal Drugs and Biologics Product Introduction
10.3.5 Alimera Sciences Recent Development
10.4 Janssen Biotech
10.4.1 Janssen Biotech Company Details
10.4.2 Company Description and Business Overview
10.4.3 Sales, Revenue and Market Share of Retinal Drugs and Biologics
10.4.4 Retinal Drugs and Biologics Product Introduction
10.4.5 Janssen Biotech Recent Development
10.5 Swedish Orphan Biovitrum
10.5.1 Swedish Orphan Biovitrum Company Details
10.5.2 Company Description and Business Overview
10.5.3 Sales, Revenue and Market Share of Retinal Drugs and Biologics
10.5.4 Retinal Drugs and Biologics Product Introduction
10.5.5 Swedish Orphan Biovitrum Recent Development
10.6 Roche
10.6.1 Roche Company Details
10.6.2 Company Description and Business Overview
10.6.3 Sales, Revenue and Market Share of Retinal Drugs and Biologics
10.6.4 Retinal Drugs and Biologics Product Introduction
10.6.5 Roche Recent Development
10.7 Bristol-Myers Squibb
10.7.1 Bristol-Myers Squibb Company Details
10.7.2 Company Description and Business Overview
10.7.3 Sales, Revenue and Market Share of Retinal Drugs and Biologics
10.7.4 Retinal Drugs and Biologics Product Introduction
10.7.5 Bristol-Myers Squibb Recent Development
10.8 Genzyme
10.8.1 Genzyme Company Details
10.8.2 Company Description and Business Overview
10.8.3 Sales, Revenue and Market Share of Retinal Drugs and Biologics
10.8.4 Retinal Drugs and Biologics Product Introduction
10.8.5 Genzyme Recent Development
10.9 Genentech
10.9.1 Genentech Company Details
10.9.2 Company Description and Business Overview
10.9.3 Sales, Revenue and Market Share of Retinal Drugs and Biologics
10.9.4 Retinal Drugs and Biologics Product Introduction
10.9.5 Genentech Recent Development
10.10 OCULAR THERAPEUTIX
10.10.1 OCULAR THERAPEUTIX Company Details
10.10.2 Company Description and Business Overview
10.10.3 Sales, Revenue and Market Share of Retinal Drugs and Biologics
10.10.4 Retinal Drugs and Biologics Product Introduction
10.10.5 OCULAR THERAPEUTIX Recent Development
10.11 Bausch & Lomb
10.12 UCBCares
11 Value Chain and Sales Channels Analysis
11.1 Value Chain Analysis
11.2 Sales Channels Analysis
11.2.1 Retinal Drugs and Biologics Sales Channels
11.2.2 Retinal Drugs and Biologics Distributors
11.3 Retinal Drugs and Biologics Customers
12 Market Forecast
12.1 Global Retinal Drugs and Biologics Sales and Revenue Forecast 2020-2025
12.2 Global Retinal Drugs and Biologics Sales Forecast by Type
12.3 Global Retinal Drugs and Biologics Sales Forecast by Application
12.4 Retinal Drugs and Biologics Forecast by Regions
12.4.1 Global Retinal Drugs and Biologics Sales Forecast by Regions 2020-2025
12.4.2 Global Retinal Drugs and Biologics Revenue Forecast by Regions 2020-2025
12.5 United States Market Forecast
12.6 European Union Market Forecast
12.7 China Market Forecast
12.8 Rest of World
12.8.1 Japan
12.8.2 Korea
12.8.3 India
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
